Duloxetine
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Back Pain Lower Back Chronic
Conditions
Back Pain Lower Back Chronic
Trial Timeline
Sep 1, 2013 → Dec 1, 2014
NCT ID
NCT01914666About Duloxetine
Duloxetine is a phase 3 stage product being developed by Shionogi for Back Pain Lower Back Chronic. The current trial status is completed. This product is registered under clinical trial identifier NCT01914666. Target conditions include Back Pain Lower Back Chronic.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02335346 | Phase 3 | Completed |
| NCT01914666 | Phase 3 | Completed |
| NCT01621191 | Phase 3 | Completed |
Competing Products
20 competing products in Back Pain Lower Back Chronic